Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Antiviral Treatment Guidelines for Middle East Respiratory Syndrome

Authors
Chong, Yong PilSong, Joon YoungBin Seo, YuChoi, Jae-PhilShin, Hyoung-Shik
Issue Date
9월-2015
Publisher
KOREAN SOC CHEMOTHERAPY
Keywords
MERS; Coronavirus; Antiviral; Treatment
Citation
INFECTION AND CHEMOTHERAPY, v.47, no.3, pp.212 - 222
Indexed
SCOPUS
KCI
Journal Title
INFECTION AND CHEMOTHERAPY
Volume
47
Number
3
Start Page
212
End Page
222
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/92595
DOI
10.3947/ic.2015.47.3.212
ISSN
2093-2340
Abstract
Middle East respiratory syndrome (MERS) is an acute infectious disease of the respiratory system caused by the new betacoronavirus (MERS coronavirus, MERS-CoV), which shows high mortality rates. The typical symptoms of MERS are fever, cough, and shortness of breath, and it is often accompanied by pneumonia. The MERS-CoV was introduced to Republic of Korea in May 2015 by a patient returning from Saudi Arabia. The disease spread mostly through hospital infections, and by the time the epidemic ended in August, the total number of confirmed diagnoses was 186, among which 36 patients died. Reflecting the latest evidence for antiviral drugs in the treatment of MERS-CoV infection and the experiences of treating MERS patients in Republic of Korea, these guidelines focus on antiviral drugs to achieve effective treatment of MERS-CoV infections.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE